VTVT - vTv Therapeutics Inc
32.76
-2.090 -6.380%
Share volume: 129,106
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$34.85
-2.09
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-20-2025 | 05-15-2025 | 08-12-2025 | 11-06-2025 | |
| Total revenue | 1.000 M | 0.000 | 0.000 | 17.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.000 M | 0.000 | 0.000 | 17.000 K | 0.000 | 0.000 | 0.000 | |
| -100.00% | nan% | inf% | -100.00% | nan% | nan% | |||
| Operating expenses | 6.627 M | 7.155 M | 6.506 M | 4.909 M | 6.503 M | 7.721 M | 10.699 M | |
| Selling general and admin | 3.978 M | 3.716 M | 3.282 M | 2.675 M | 3.673 M | 3.618 M | 3.679 M | |
| Research and development | 2.649 M | 3.439 M | 3.224 M | 2.234 M | 2.830 M | 4.103 M | 7.020 M | |
| Total expenses | 6.627 M | 7.155 M | 6.506 M | 4.909 M | 6.503 M | 7.721 M | 10.699 M | |
| 7.97% | -9.07% | -24.55% | 32.47% | 18.73% | 38.57% | |||
| Operating income | -5.627 M | -7.155 M | -6.506 M | -4.892 M | -6.503 M | -7.721 M | -10.699 M | |
| Ebit | -5.998 M | -6.962 M | -6.344 M | -4.866 M | -6.548 M | -7.655 M | -10.739 M | |
| Pretax income | -5.919 M | -6.409 M | -5.840 M | -4.437 M | -6.217 M | -7.380 M | -10.345 M | |
| 8.28% | -8.88% | -24.02% | 40.12% | 18.71% | 40.18% | |||
| Income tax | 100.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.019 M | -6.409 M | -5.840 M | -4.437 M | -6.217 M | -7.380 M | -10.345 M | |
| -6.48% | 8.88% | 24.02% | -40.12% | -18.71% | -40.18% |